Inhibrx Biosciences Inc's total assets for Q4 2025 were $146.48M, a decrease of -17.46% from the previous quarter. INBX total liabilities were $138.49M for the fiscal quarter, a -1.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.